Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) has issued a profit forecast, expecting a net profit of 1.43 billion yuan for the year 2024, an increase of 121.99% year-on-year.

20/01/2025

Aeris (688578.SH) released an announcement, stating that the company expects to achieve a net profit attributable to the owner of the parent company in 2024...

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) announced that the company expects to achieve a net profit attributable to the owners of the parent company of 1.43 billion yuan in 2024, a year-on-year increase of 121.99%. The main reasons for the performance growth are: The company's core product, Fumitelanib mesylate tablets, was renewed and included in the national medical insurance catalog, leading to continuous growth in sales revenue. At the same time, the company has effectively implemented a number of cost reduction and efficiency improvement measures, strict control over various costs and expenses, resulting in a significant improvement in the company's performance.

HK Stock Market Move | UBOX ONLINE(02429) gave back over 20% of its gains in the morning session. The previous trading day saw a significant increase of over 50% in trading volume.

HK Stock Market Move | CHINA RES BEER (00291) rises more than 3%, institutions say that the change of chairman should not cause major changes in the company's strategy, still have confidence in sustainable growth.

HK Stock Market Move | SYNAGISTICS(02562) rose more than 8%. The company previously announced the acquisition of a SaaS enterprise, which is expected to bring revolutionary synergies.

HK Stock Market Move | UBOX ONLINE(02429) gave back over 20% of its gains in the morning session. The previous trading day saw a significant increase of over 50% in trading volume.

HK Stock Market Move | SYNAGISTICS(02562) rose more than 8%. The company previously announced the acquisition of a SaaS enterprise, which is expected to bring revolutionary synergies.